<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on February 03, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00001741</url>
  </required_header>
  <id_info>
    <org_study_id>980029</org_study_id>
    <secondary_id>98-H-0029</secondary_id>
    <nct_id>NCT00001741</nct_id>
  </id_info>
  <brief_title>Study of Inherited Changes of Receptors Located on Blood Vessels</brief_title>
  <official_title>Study of Vascular Responsiveness in Subjects With Polymorphisms of the Angiotensin II Type I Receptor Gene</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Heart, Lung, and Blood Institute (NHLBI)</agency>
      <agency_class>NIH</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Institutes of Health Clinical Center (CC)</source>
  <brief_summary>
    <textblock>
      The renin angiotensin system is a complex process involving hormones and enzymes that&#xD;
      regulate blood volume and blood pressure. The hormone angiotensin II is responsible for&#xD;
      making blood vessels narrow or constrict. Angiotensin II is found in the blood and can attach&#xD;
      to special sites called receptors on blood vessel walls. These receptors are programmed to&#xD;
      accept angiotensin II and cause a constriction of the blood vessel. This function is found in&#xD;
      the genetic information of each individual person.&#xD;
&#xD;
      Occasionally patients have changes in their genes related to angiotensin II receptors. These&#xD;
      changes may result in the receptors acting differently to angiotensin II, which may affect&#xD;
      the function of blood vessels.&#xD;
&#xD;
      This study is designed to improve researchers understanding of the physiological effects on&#xD;
      blood vessels associated with mutations of the genes responsible for angiotensin II receptor&#xD;
      function.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Polymorphisms in the genes encoding for various elements of the renin angiotensin system have&#xD;
      been associated with cardiovascular disease. We have isolated novel alleles in the&#xD;
      angiotensin II type I receptor gene. We propose this exploratory investigation to study the&#xD;
      physiological effect of these mutations on vascular function in patients and family members&#xD;
      who carry these rare alleles.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 1997</start_date>
  <completion_date>April 2003</completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <primary_purpose>Treatment</primary_purpose>
  </study_design_info>
  <enrollment>200</enrollment>
  <condition>Cardiovascular Disease</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Losartan</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Patients aged 21 or older with chronic orthostatic intolerance will be included.&#xD;
&#xD;
        There will be no exclusion from participation in the study on the basis of ethnicity/race.&#xD;
&#xD;
        Patients will be recruited in the Cardiology Branch outpatient clinic, Dr. David Goldstein&#xD;
        (Chief Neurocardiology Section, NINDS, NIH), or from outside physicians.&#xD;
&#xD;
        Children will be excluded from the study because of inability in obtaining informed&#xD;
        consent.&#xD;
&#xD;
        Cognitively impaired individuals, prisoners, or other institutionalized persons will not be&#xD;
        able to participate.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>National Heart, Lung and Blood Institute (NHLBI)</name>
      <address>
        <city>Bethesda</city>
        <state>Maryland</state>
        <zip>20892</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest. 1990 Oct;86(4):1343-6. doi: 10.1172/JCI114844.</citation>
    <PMID>1976655</PMID>
  </reference>
  <reference>
    <citation>Cambien F, Poirier O, Lecerf L, Evans A, Cambou JP, Arveiler D, Luc G, Bard JM, Bara L, Ricard S, et al. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature. 1992 Oct 15;359(6396):641-4. doi: 10.1038/359641a0.</citation>
    <PMID>1328889</PMID>
  </reference>
  <reference>
    <citation>Alderman MH, Madhavan S, Ooi WL, Cohen H, Sealey JE, Laragh JH. Association of the renin-sodium profile with the risk of myocardial infarction in patients with hypertension. N Engl J Med. 1991 Apr 18;324(16):1098-104. doi: 10.1056/NEJM199104183241605.</citation>
    <PMID>1759997</PMID>
  </reference>
  <verification_date>April 2003</verification_date>
  <study_first_submitted>November 3, 1999</study_first_submitted>
  <study_first_submitted_qc>November 3, 1999</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 4, 1999</study_first_posted>
  <last_update_submitted>March 3, 2008</last_update_submitted>
  <last_update_submitted_qc>March 3, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 4, 2008</last_update_posted>
  <keyword>Angiotensin II Receptor</keyword>
  <keyword>Polymorphism, Genetic</keyword>
  <keyword>Vascular Tone</keyword>
  <keyword>Angiotensin II</keyword>
  <keyword>Losartan</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cardiovascular Diseases</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Losartan</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

